Even though the sizes of treatment effects appear to be rather moderate in their magnitude, they should be valued against the background of the relapsing nature of alcoholism and the limited therapeutic options
PHQ-9: patient health questionnaire 9, PACS: Penn alcohol craving scale, GAD-7, general anxiety disorder 7. The Mayo Clinic Center for the Individualized Treatment of Alcoholism study (ClinicalTrials.gov Identifier: NCT00662571) was conducted under a protocol approved by the Mayo Clinic ...
Alcohol misuse accounts for a sizeable proportion of the global burden of disease, and Campral® (acamprosate; calcium-bis-(N-acetylhomotaurinate)) is widely used as relapse prevention therapy. The mechanism underlying its effect has in some studies be
Acamprosate has been widely used since the Food and Drug Administration approved the medication for treatment of alcohol use disorders (AUDs) in 2004. Although the detailed molecular mechanism of acamprosate remains unclear, it has been largely known tha
ALCOHOLISMThe patient was assessed on the Naranjo Adverse Drug Reaction Probability Scale and scored 9, which advocates a definite chance of adverse drug reaction. Hence, when encounters such patient, one should keep in mind acamprosate-induced myoclonic jerks for better management and ...
The incidence of side effects was low, 12%, all of them mild. Conclusion: Acamprosate, a drug used in the treatment of alcoholism, is a safe and successful alternative for sensorineural tinnitus' treatment.AndréiaA.AzevedoRicardoR.Figueiredo...